Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFASITAMAB vs TAFLUPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFASITAMAB vs TAFLUPROST: Safety Overview

Metric TAFASITAMAB TAFLUPROST
Total FAERS Reports 1,392 1,677
Deaths Reported 475 282
Death Rate 34.1% 16.8%
Hospitalizations 433 75
Average Patient Age 70.0 yrs 76.0 yrs
% Female Patients 50.1% 73.5%
FDA Approval Date N/A Apr 5, 2024
Manufacturer Incyte Corporation Micro Labs Limited
Route INTRAVENOUS OPHTHALMIC
Marketing Status N/A Prescription